EUCTR2021-006754-31-NL进行中（未招募）1 期
Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers - MILESTONE: iMmunogenicity IntradermaL cEramic Skin paTch sars-cOv-2 vacciNE
eiden University Medical Center0 个研究点目标入组 20 人开始时间: 2022年2月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •primary vaccination series with Comirnaty
- •not immunocompromised
- •not pregnant
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •having had covid-19 (anti-N and PCR)
- •having received a covid-19 booster
- •use of corticosteroids (systemic of topical)
- •use of other immunesuppressants
研究者
相似试验
已完成
2 期
Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteersNL-OMON51606eids Universitair Medisch Centrum20
已完成
不适用
Assessment of the immunogenicity and safety of the Northern Hemisphere 2010/2011-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulationsInfluenzaISRCTN89337058Crucell Switzerland AG (Switzerland)110
已完成
不适用
Assessment of the immunogenicity and safety of the Northern Hemisphere 2009/2010-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulationsInfluenzaISRCTN30202688Crucell, Berna Biotech Ltd (Switzerland)110
已完成
不适用
Assessment of the immunogenicity and safety of the Northern Hemisphere 2009/2010-season influenza vaccine in children aged 6 to 35 months in comparison to a commercially available influenza vaccineRespiratoryInfluenza, virus not identifiedInfluenzaISRCTN10483274Berna Biotech Ltd, a Crucell Company (Switzerland)1,239
已完成
不适用
Assessment of the immunogenicity and safety of the Northern Hemisphere 2008/2009-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulationsInfluenzaISRCTN40098615Crucell, Berna Biotech Ltd (Switzerland)110